Addus Homecare (ADUS) Upgraded at Zacks Investment Research

Addus Homecare (NASDAQ:ADUS) was upgraded by Zacks Investment Research from a “strong sell” rating to a “hold” rating in a report issued on Tuesday.

According to Zacks, “ADDUS HOMECARE is a comprehensive provider of a broad range of social and medical services in the home. The company’s services include personal care and assistance with activities of daily living, skilled nursing and rehabilitative therapies, and adult day care. Its consumers are individuals with special needs who are at risk of hospitalization or institutionalization, such as the elderly, chronically ill and disabled. Its payor clients include federal, state and local governmental agencies, the Veterans Health Administration, commercial insurers and private individuals. Addus operates its business through two divisions, home & community services and home health services. The home & community services are social, or non-medical, in nature and include assistance with bathing, grooming, dressing, personal hygiene and medication reminders, and other activities of daily living whereas the home health services are medical in nature and include physical, occupational and speech therapy, as well as skilled nursing. “

A number of other analysts have also commented on ADUS. Oppenheimer reaffirmed a “buy” rating and issued a $45.00 target price on shares of Addus Homecare in a research report on Tuesday, September 19th. BidaskClub raised Addus Homecare from a “sell” rating to a “hold” rating in a research report on Friday, January 5th. Three investment analysts have rated the stock with a hold rating and two have assigned a buy rating to the company’s stock. The company presently has a consensus rating of “Hold” and an average target price of $41.33.

Addus Homecare (NASDAQ ADUS) opened at $36.65 on Tuesday. The stock has a market capitalization of $424.30, a PE ratio of 23.95, a PEG ratio of 1.59 and a beta of 0.17. The company has a debt-to-equity ratio of 0.23, a current ratio of 2.68 and a quick ratio of 2.68. Addus Homecare has a 52 week low of $29.90 and a 52 week high of $40.75.

Addus Homecare (NASDAQ:ADUS) last issued its earnings results on Monday, November 6th. The company reported $0.42 EPS for the quarter, beating analysts’ consensus estimates of $0.38 by $0.04. Addus Homecare had a return on equity of 10.35% and a net margin of 4.30%. The business had revenue of $108.60 million during the quarter, compared to analyst estimates of $108.99 million. During the same period in the previous year, the company posted $0.39 EPS. The firm’s revenue was up 4.9% compared to the same quarter last year. sell-side analysts predict that Addus Homecare will post 1.42 earnings per share for the current fiscal year.

A number of institutional investors and hedge funds have recently modified their holdings of ADUS. Oppenheimer & Co. Inc. increased its holdings in Addus Homecare by 18.6% during the 2nd quarter. Oppenheimer & Co. Inc. now owns 20,536 shares of the company’s stock worth $764,000 after purchasing an additional 3,225 shares in the last quarter. JPMorgan Chase & Co. increased its holdings in Addus Homecare by 5.7% during the 2nd quarter. JPMorgan Chase & Co. now owns 274,000 shares of the company’s stock worth $10,192,000 after purchasing an additional 14,717 shares in the last quarter. Los Angeles Capital Management & Equity Research Inc. bought a new stake in Addus Homecare during the 2nd quarter worth approximately $264,000. Wells Fargo & Company MN increased its holdings in Addus Homecare by 12.3% during the 2nd quarter. Wells Fargo & Company MN now owns 54,035 shares of the company’s stock worth $2,010,000 after purchasing an additional 5,923 shares in the last quarter. Finally, AJO LP increased its holdings in Addus Homecare by 83.9% during the 2nd quarter. AJO LP now owns 95,277 shares of the company’s stock worth $3,544,000 after purchasing an additional 43,475 shares in the last quarter. 92.97% of the stock is owned by hedge funds and other institutional investors.

TRADEMARK VIOLATION NOTICE: This piece of content was published by Markets Daily and is the property of of Markets Daily. If you are reading this piece of content on another publication, it was illegally stolen and republished in violation of United States and international copyright law. The correct version of this piece of content can be read at https://www.themarketsdaily.com/2018/01/11/addus-homecare-adus-upgraded-at-zacks-investment-research.html.

About Addus Homecare

Addus HomeCare Corporation is a provider of personal care services, which are provided primarily in the home. The Company’s personal care services include assistance with bathing, grooming, oral care, skincare, assistance with feeding and dressing, medication reminders, meal planning and preparation, housekeeping and transportation services and other activities of daily living.

Get a free copy of the Zacks research report on Addus Homecare (ADUS)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Addus Homecare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Addus Homecare and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply